Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2
暂无分享,去创建一个
Douglas B. Johnson | A. Alva | J. Dutcher | U. Vaishampayan | R. Hauke | H. Kaufman | Joseph I. Clark | B. Curti | E. Davis | T. Logan | P. Wiernik | A. Amin | R. White | G. Miletello | E. J. Davis